Trial intelligence / Profile preview

COMBOKA pilot study

2008-002694-13Phase 4Terminated

Sponsor
Fundación Biomédica Galicia Sur
Start
Apr 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial in human immunodeficiency virus infection (HIV) comparing Kaletra + Kivexa with Kaletra + Truvada (2 arms). Started Apr 2009; status: terminated.

02

Drugs

abacavir + lamivudineemtricitabine + tenofovir disoproxillopinavir + ritonavir
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on 2008-002694-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-002694-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call